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Why Should We Prevent
Polypharmacy?
At the beginning of this year, drug labelling became
effectively mandatory in Hong Kong because of legislative
changes. On the one hand, we, as doctors, have more
information on what the patients are taking. On the other
hand, the issue of polypharmacy has also begun to emerge.
In this issue of the Journal, Dr. Auyeung Tung Wai and his
colleagues take a critical look at the prevalence of polypharmacy
among patients attending their specialist geriatric out-patient
clinics. Their prevalence is 72 per 1,000 of their clinic patients.
In their study, they had defined polypharmacy as greater than 4
regular oral or injectable drugs.
Because of differences in the age of the patient population,
general practitioners may not have as many patients on regular
drugs as geriatricians. Therefore, we may need a different
definition when we discuss polypharmacy in general practice. I
personally think that even one unnecessary medication is
polypharmacy.1 However, in my experience, patients are often
taking more than just one unnecessary medication. A patient on
sixteen medications was reported in Australia last year.2 I
personally have seen an elderly patient who was put on eleven
different items after a consultation with a fellow doctor in Hong
Kong earlier this year. Some of these items contained multiple
active agents. This patient attended my clinic because of
dizziness and palpitation after taking these medications.
With the recent rapid advances in medical and
pharmaceutical research, many new drugs are being marketed
every year. Most research resulting in the development and
marketing of these medications has been directed at proving the
efficacy and safety of single drug products. Little research has
been directed to determine the safety and efficacy of combining
multiple medications in a single patient, whether to treat
concurrent conditions or not.3 We are therefore subjecting our
patients to possible unknown pharmacological interactions which
may have serious and significant harmful effects. This is a
particular problem in the very young and very old who are more
prone to these harmful effects. When polypharmacy is
associated with unnecessary injections, extra pain is suffered
especially in paediatric patients.
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Editorial
Polypharmacy costs money. It encourages
drug dependency. It also leads to non-compliance
because of the complexity of the medication
regimes. It could result in essential drugs not
being taken while unnecessary drugs are
consumed.
The job of a doctor is to teach patients rather
than just giving out pills.4 Improved
undergraduate and postgraduate medical
education in the area of therapeutics will help
prevent polypharmacy. Doctors must regularly
and actively review the drug regime of patients
with chronic problems.5 The goal should be to
prescribe the least complex drug regimen possible
for the patient, while still taking into consideration
the medical problems and symptoms and the cost
of therapy.1 Educating patients on the limitations
and specific uses of medication, and sharing
the decisions for making the treatment goals and
plans, will help reduce the demands and
expectations patients have of physicians for drug
therapy.3
In conclusion, polypharmacy is costly to the
health system and harmful to patients. Education
for doctors and patients will help reduce the risk
of polypharmacy. •
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*** *** *** *** ***
ERRATUM
Are Doctors Communicating Well Enough? 1995; 17(7): 297-298. An
error occurred in this Editorial by Dr. David V.K. Chao on page 297, 2nd
paragraph, line 8 "letters to a geriatric . . . . (page no. 314)" was wrongly
listed. It should read "page no. 323."
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